News Conference News TCT 2024 Few Patients Under 65 Get TAVI: Those Who Do Are Especially Sick Yael L. Maxwell November 07, 2024
News Conference News TCT 2024 Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI Michael O'Riordan November 06, 2024
News Conference News TCT 2024 After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry Yael L. Maxwell November 05, 2024
News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News TCT 2022 Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances Caitlin E. Cox September 19, 2022
News Conference News TCT 2021 TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3 Yael L. Maxwell November 05, 2021
News Conference News TCT 2021 SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years Todd Neale November 05, 2021
News Conference News TCT 2020 Sapien 3 Stroke Rate Perplexes in 1-Year SOLVE-TAVI Results Michael O'Riordan October 16, 2020
News Conference News TCT 2020 MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions Shelley Wood October 15, 2020
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
News Conference News TCT 2018 PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience L.A. McKeown September 27, 2018
News Conference News TCT 2017 3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike Yael L. Maxwell October 31, 2017
News Conference News TCT 2015 DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year October 12, 2015
News Conference News TCT 2015 CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years October 12, 2015